| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697504 | Cancer Treatment and Research Communications | 2017 | 25 Pages |
Abstract
Bevacizumab was prescribed less frequently than expected, offered to a selected population and frequently outside guideline recommendations. Early field research on the implementation, use and effectiveness of new drugs in daily practice is necessary to guarantee effective implementation of these drugs.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R.J.W. van Kampen, D.J.A. Lobbezoo, M. de Boer, M.W. Dercksen, A.C. Voogd, F. van den Berkmortel, T.J. Smilde, A.J. van de Wouw, F.P.J. Peters, J.M.G. van Riel, N.A.J.B. Peters, P.G.M. Peer, M.A. Joore, V.C.G. Tjan-Heijnen,